Rapid Dose Therapeutics Corp.
RDTCF
$0.08
-$0.01-15.56%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.79% | 17.35% | 6.27% | -21.13% | -60.18% |
| Total Depreciation and Amortization | 22.17% | -21.34% | -49.42% | -62.13% | -50.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.05% | 15.08% | 42.25% | 169.82% | 589.58% |
| Change in Net Operating Assets | 74.93% | 912.08% | 959.79% | 171.74% | -75.91% |
| Cash from Operations | 61.82% | 67.13% | 66.28% | 50.39% | -126.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 365.82% | -69.29% | -95.18% | -98.77% | -94.35% |
| Total Debt Repaid | 75.52% | 52.43% | 73.45% | 72.55% | 73.26% |
| Issuance of Common Stock | -99.05% | -77.15% | -57.43% | 5.22% | 9,695.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 497.89% | 497.89% | 345.51% | -- | -61.12% |
| Cash from Financing | -56.51% | -65.22% | -68.39% | -58.66% | 90.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 153.47% | 52.54% | -148.46% | -201.19% | -187.48% |